|
CREBZF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.082400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.068160E-02 |
| Normal-vs-Stage2 |
8.778500E-02 |
| Normal-vs-Stage3 |
8.209400E-01 |
| Normal-vs-Stage4 |
4.849200E-01 |
| Stage1-vs-Stage2 |
5.228800E-01 |
| Stage1-vs-Stage3 |
1.115990E-01 |
| Stage1-vs-Stage4 |
5.306400E-01 |
| Stage2-vs-Stage3 |
1.286790E-01 |
| Stage2-vs-Stage4 |
3.847800E-01 |
| Stage3-vs-Stage4 |
6.717800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.282700E-03 |
| Normal-vs-AfricanAmerican |
3.965800E-02 |
| Normal-vs-Asian |
7.716000E-01 |
| Caucasian-vs-AfricanAmerican |
7.921400E-01 |
| Caucasian-vs-Asian |
2.264200E-01 |
| AfricanAmerican-vs-Asian |
3.295000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.757100E-03 |
| Normal-vs-Female |
1.626140E-02 |
| Male-vs-Female |
9.658800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.285700E-02 |
| Normal-vs-Extreme_Weight |
4.145600E-02 |
| Normal-vs-Obese |
6.824600E-03 |
| Normal-vs-Extreme_Obese |
2.932000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.251400E-01 |
| Normal_Weight-vs-Obese |
3.900000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.531800E-01 |
| Extreme_Weight-vs-Obese |
3.750200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.160600E-01 |
| Obese-vs-Extreme_Obese |
5.019000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.994030E-02 |
| Normal-vs-Age(41-60Yrs) |
3.230600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.758200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.622600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.775400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.749410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.266300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.333900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.396300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.62379999999207E-06 |
| Normal-VS-Type2 PRCC |
1.795380E-01 |
| Normal-VS-KIRP CIMP |
8.781800E-02 |
| Normal-VS-Unclassified PRCC |
4.558100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.32456284724003E-12 |
| Type1 PRCC-VS-KIRP CIMP |
5.293600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.705780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.777200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.775110E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.715600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.710800E-01 |
| Normal-vs-N1 |
2.459000E-01 |
| Normal-vs-N2 |
5.440400E-01 |
| N0-vs-N1 |
5.277800E-01 |
| N0-vs-N2 |
4.036200E-01 |
| N1-vs-N2 |
7.190100E-02 |
|
|
